1. P352 A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. (27th May 2021) Authors: Lenti, M V; Dolby, V; Clark, T; Hall, V; Tattersall, S; Fairhurst, F; Kenneth, C; Walker, R; Kemp, K; Borg-Bartolo, S; Limdi, J; Taylor, J; Townsend, T; Subramanian, S; Storey, D; Assadsangabi, A; Stansfield, C; Smith, P; Byrne, D; De Silvestri, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P423 Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis. (25th January 2019) Authors: Subramanian, S; Davis, R; MacParland, P; Dodd, S; Storey, D; Probert, C; Collins, P; Skouras, T; Steel, A; Derbyshire, E; Dibb, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P496 Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study. (27th May 2021) Authors: Smith, P J; Storey, D; Gregg, B; Critchley, L; Stenson, J; Kneebone, A; Rimmer, T; Burke, S; Hussain, S; Teoh, W Y; Vazeille, S; Serna, S; Bond, A; Steel, A; Dibb, M; Collins, P; Derbyshire, E; Bodger, K; Probert, C; Verma, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P586 Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn's disease: a multi-centre retrospective cohort study. (25th January 2019) Authors: Townsend, T; Razanskaite, V; Michail, S; Morgan, J; Davies, M; Storey, D; Watters, C; Penman, D; Swaminathan, M; Sabine, J; Chapman, A; Vyas, A; Reilly, I; Flanagan, P; Bodger, K; Subramanian, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PTH-074 Baseline calprotectin does not predict response to biological therapy in ulcerative colitis. (17th June 2017) Authors: Storey, D; Skouras, T; Bond, A; Dodd, S; Subramanian, S Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PWE-062 Effectiveness and safety of vedolizumab (vdz) in ibd patients: a multicentre experience of 'real world data' from the uk. (17th June 2017) Authors: Lenti, MV; Levison, S; Eliadou, E; Willert, R Robert; Kemp, K; Stansfield, C; Assadsangabi, A; Singh, S; Crooks, B; Tattersall, S; Kenneth, C; Subramanian, S; Probert, C; Storey, D; Gregg, B; Smith, P; Liu, E; Limdi, JK; Johnston, A; Hamlin, PJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗